Abstract Details
|
James W. Bathe
(Wayne State University Department of Neurology)
PRESENTER |
No disclosure on file |
| Deepti Zutshi, MD, FAAN (Wayne State University School of Medicine) | Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta. |
| Rohit A. Marawar, MD, FAAN (Wayne State University - Detroit Medical Center) | Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Marawar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. |
| Maysaa M. Basha, MD, FAAN (Wayne State University, Detroit Medical Center) | Dr. Basha has nothing to disclose. |
| Aashit K. Shah, MD, FAAN (Carilion Clinic) | Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma. |